While in MSI CRC missense mutations in KRAS and TP53 (and in any gene) can be accounted for by the strong mutator phenotype displayed by these tumors, in CRC without MSI the origin of these oncogenic mutations remains unclear [14]. Here, KRAS is linked to colorectal carcinoma.